Literature DB >> 8590982

Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices.

W Y Chang1, R A Webster.   

Abstract

1. The effect of L-dopa on the spontaneous and KCl-evoked efflux of dopamine from rat striatal slices, measured by high performance liquid chromatography (h.p.l.c.) with electrochemical detection (e.c.d.) was investigated in the absence and presence of 3-O-methyl dopa (OMD), an O-methylated metabolite of L-dopa. 2. The addition of exogenous L-dopa (10 microM) significantly increased both the spontaneous efflux of dopamine and that evoked by KCl. 3. In the presence of 50 microM OMD, the effects of L-dopa on the spontaneous and KCl-evoked efflux of dopamine were smaller but only the former was significantly different from that in the absence of OMD. However, the total efflux of dopamine during the overall superfusion time (70 min) including KCl depolarization was significantly lower than in the absence of OMD. 4. Analysis of tissue content after superfusion revealed that the levels of dopa and dopamine in slices superfused with L-dopa in the presence of OMD were significantly higher than those superfused with L-dopa alone. 5. The finding that OMD significantly reduced the efflux of dopamine whilst increasing its concentration in striatal slices after L-dopa superfusion could explain the reduced efficacy seen after long-term therapy with L-dopa and a peripheral dopa decarboxylase inhibitor in Parkinsonian patients when plasma and brain OMD are very high.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590982      PMCID: PMC1909121          DOI: 10.1111/j.1476-5381.1995.tb17219.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  The effects of L-dopa on in vitro dopamine release from striatum.

Authors:  G L Snyder; M J Zigmond
Journal:  Brain Res       Date:  1990-02-05       Impact factor: 3.252

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

3.  The metabolism of L-3-O-methyldopa, a precursor of dopa in man.

Authors:  I Kuruma; G Bartholini; R Tissot; A Pletscher
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

4.  A simple in vitro technique to measure the release of endogenous dopamine and dihydroxyphenylacetic acid from striatal tissue using high performance liquid chromatography with electrochemical detection.

Authors:  J B Becker; E Castañeda; T E Robinson; M E Beer
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

5.  Effects of 3-OM-dopa on monoamine metabolism in rat brain.

Authors:  J J Gervas; V Muradás; E Bazán; E G Aguado; J G de Yébenes
Journal:  Neurology       Date:  1983-03       Impact factor: 9.910

6.  Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.

Authors:  M Merello; A J Lees; R Webster; M Bovingdon; A Gordin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 7.  Problems and unanswered questions concerning levodopa treatment in Parkinson's disease.

Authors:  R J Hardie
Journal:  Acta Neurol Scand Suppl       Date:  1989

8.  Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.

Authors:  Y Goshima; T Kubo; Y Misu
Journal:  J Neurochem       Date:  1988-06       Impact factor: 5.372

9.  Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.

Authors:  G Fabbrini; J Juncos; M M Mouradian; C Serrati; T N Chase
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

10.  Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.

Authors:  G M Tyce; D K Rorie
Journal:  Life Sci       Date:  1985-12-23       Impact factor: 5.037

View more
  2 in total

1.  The role of 3-O-methyldopa in the side effects of L-dopa.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Jennifer King; Clivel Charlton
Journal:  Neurochem Res       Date:  2007-08-24       Impact factor: 3.996

2.  3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.

Authors:  Masato Asanuma; Ikuko Miyazaki
Journal:  BMC Neurosci       Date:  2016-07-25       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.